297 related articles for article (PubMed ID: 31941495)
1. Biodistribution, biocompatibility and targeted accumulation of magnetic nanoporous silica nanoparticles as drug carrier in orthopedics.
Janßen HC; Angrisani N; Kalies S; Hansmann F; Kietzmann M; Warwas DP; Behrens P; Reifenrath J
J Nanobiotechnology; 2020 Jan; 18(1):14. PubMed ID: 31941495
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo accumulation of magnetic nanoporous silica nanoparticles on implant materials with different magnetic properties.
Janßen HC; Warwas DP; Dahlhaus D; Meißner J; Taptimthong P; Kietzmann M; Behrens P; Reifenrath J; Angrisani N
J Nanobiotechnology; 2018 Nov; 16(1):96. PubMed ID: 30482189
[TBL] [Abstract][Full Text] [Related]
3. Preparation and PET/CT imaging of implant directed
Polyak A; Harting H; Angrisani N; Herrmann T; Ehlert N; Meißner J; Willmann M; Al-Bazaz S; Ross TL; Bankstahl JP; Reifenrath J
J Nanobiotechnology; 2023 Aug; 21(1):270. PubMed ID: 37592318
[TBL] [Abstract][Full Text] [Related]
4. Improved anticancer efficacy of epirubicin by magnetic mesoporous silica nanoparticles: in vitro and in vivo studies.
Ansari L; Jaafari MR; Bastami TR; Malaekeh-Nikouei B
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):594-606. PubMed ID: 29688064
[TBL] [Abstract][Full Text] [Related]
5. Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.
Jie LY; Cai LL; Wang LJ; Ying XY; Yu RS; Zhang MM; Du YZ
Int J Nanomedicine; 2012; 7():3981-9. PubMed ID: 22866005
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
7. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
8. Influence of PEG Chain Length of Functionalized Magnetic Nanoparticles on the Cytocompatibility and Immune Competence of Primary Murine Macrophages and Dendritic Cells.
Storjohann R; Gericke B; Reifenrath J; Herrmann T; Behrens P; Oltmanns H; Meißner J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768890
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol.
Ruiz A; Hernández Y; Cabal C; González E; Veintemillas-Verdaguer S; Martínez E; Morales MP
Nanoscale; 2013 Dec; 5(23):11400-8. PubMed ID: 23832394
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
[TBL] [Abstract][Full Text] [Related]
11. Monodisperse magnetofluorescent nanoplatforms for local heating and temperature sensing.
Zhang H; Huang H; He S; Zeng H; Pralle A
Nanoscale; 2014 Nov; 6(22):13463-9. PubMed ID: 25308371
[TBL] [Abstract][Full Text] [Related]
12. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe3O4 nanoparticle cores and a PEG-functionalized porous silica shell.
Chen FH; Zhang LM; Chen QT; Zhang Y; Zhang ZJ
Chem Commun (Camb); 2010 Dec; 46(45):8633-5. PubMed ID: 20941412
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
[TBL] [Abstract][Full Text] [Related]
15. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
[TBL] [Abstract][Full Text] [Related]
16. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution.
Shao D; Lu MM; Zhao YW; Zhang F; Tan YF; Zheng X; Pan Y; Xiao XA; Wang Z; Dong WF; Li J; Chen L
Acta Biomater; 2017 Feb; 49():531-540. PubMed ID: 27836804
[TBL] [Abstract][Full Text] [Related]
17. Organosilane and Polyethylene Glycol Functionalized Magnetic Mesoporous Silica Nanoparticles as Carriers for CpG Immunotherapy In Vitro and In Vivo.
Zheng H; Wen S; Zhang Y; Sun Z
PLoS One; 2015; 10(10):e0140265. PubMed ID: 26451735
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of magnetic nanoparticles as a function of coating in a rat model.
Ruiz A; Gutiérrez L; Cáceres-Vélez PR; Santos D; Chaves SB; Fascineli ML; Garcia MP; Azevedo RB; Morales MP
Nanoscale; 2015 Oct; 7(39):16321-9. PubMed ID: 26381991
[TBL] [Abstract][Full Text] [Related]
19. Increased accumulation of magnetic nanoparticles by magnetizable implant materials for the treatment of implant-associated complications.
Angrisani N; Foth F; Kietzmann M; Schumacher S; Angrisani GL; Christel A; Behrens P; Reifenrath J
J Nanobiotechnology; 2013 Oct; 11():34. PubMed ID: 24112871
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro testing of thermoresponsive polymer-grafted core-shell magnetic mesoporous silica nanoparticles for efficient controlled and targeted drug delivery.
Peralta ME; Jadhav SA; Magnacca G; Scalarone D; Mártire DO; Parolo ME; Carlos L
J Colloid Interface Sci; 2019 May; 544():198-205. PubMed ID: 30844568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
